These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6330838)

  • 1. Immunity induced by inactivated poliovirus vaccine and excretion of virus.
    Chin TD
    Rev Infect Dis; 1984; 6 Suppl 2():S369-70. PubMed ID: 6330838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody response and viral excretion after live polio vaccine or a combined schedule of live and inactivated polio vaccines.
    Ramsay ME; Begg NT; Gandhi J; Brown D
    Pediatr Infect Dis J; 1994 Dec; 13(12):1117-21. PubMed ID: 7892081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucosal immunity induced by enhance-potency inactivated and oral polio vaccines.
    Onorato IM; Modlin JF; McBean AM; Thoms ML; Losonsky GA; Bernier RH
    J Infect Dis; 1991 Jan; 163(1):1-6. PubMed ID: 1845806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eradication of poliomyelitis in the United States. III. Poliovaccines--practical considerations.
    Salk D
    Rev Infect Dis; 1980; 2(2):258-73. PubMed ID: 6994208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Artificial herd immunity to poliomyelitis in a semirural community in South Africa.
    Winter PA; Krynauw JD; Marais GA
    S Afr Med J; 1981 Dec; 60(23):889-90. PubMed ID: 6272430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elimination of poliomyelitis in Finland.
    Lapinleimu K
    Rev Infect Dis; 1984; 6 Suppl 2():S457-60. PubMed ID: 6330841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The spread of wild poliovirus in the well-vaccinated Netherlands in connection with the 1978 epidemic.
    Schaap GJ; Bijkerk H; Coutinho RA; Kapsenberg JG; van Wezel AL
    Prog Med Virol; 1984; 29():124-40. PubMed ID: 6322230
    [No Abstract]   [Full Text] [Related]  

  • 8. Immune response to an intercalated enhanced inactivated polio vaccine/oral polio vaccine programme in Israel: impact on the control of poliomyelitis.
    Swartz TA; Handsher R; Manor Y; Stoeckel P; Barkay A; Mendelson E; Leventhal A
    Vaccine; 1998 Dec; 16(20):2090-5. PubMed ID: 9796069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poliovirus-specific memory immunity in seronegative elderly people does not protect against virus excretion.
    Abbink F; Buisman AM; Doornbos G; Woldman J; Kimman TG; Conyn-van Spaendonck MA
    J Infect Dis; 2005 Mar; 191(6):990-9. PubMed ID: 15717277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term immunity following vaccination with killed poliovirus vaccine in Sweden, a country with no circulating poliovirus.
    Böttiger M
    Rev Infect Dis; 1984; 6 Suppl 2():S548-51. PubMed ID: 6740100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative evaluation of immunization with live attenuated and inactivated poliovirus vaccines.
    Ogra PL
    Ann N Y Acad Sci; 1995 May; 754():97-107. PubMed ID: 7625685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal immunity following a combined enhanced inactivated polio vaccine/oral polio vaccine programme in Israel.
    Swartz TA; Green MS; Handscher R; Sofer D; Cohen-Dar M; Shohat T; Habib S; Barak E; Dror Z; Somekh E; Peled-Leviathan T; Yulzari R; Libling A; Mendelson E; Shulman LM
    Vaccine; 2008 Feb; 26(8):1083-90. PubMed ID: 18241962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herd effect and virus eradication with use of killed poliovirus vaccine.
    Salk D
    Dev Biol Stand; 1981; 47():247-55. PubMed ID: 6262150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modes of action of poliovirus vaccines and relation to resulting immunity.
    Fox JP
    Rev Infect Dis; 1984; 6 Suppl 2():S352-5. PubMed ID: 6740072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maxwell Finland lecture: viral vaccines and their ways.
    Horstmann DM
    Rev Infect Dis; 1979; 1(3):502-16. PubMed ID: 399363
    [No Abstract]   [Full Text] [Related]  

  • 16. Induction of long-term immunity to paralytic poliomyelitis by use of non-infectious vaccine.
    Salk D; van Wezel AL; Salk J
    Lancet; 1984 Dec; 2(8415):1317-21. PubMed ID: 6150331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies on new attenuated strains of type I live poliovirus vaccine. II. Investigation on a series of field trials with "Zhong I9" strain].
    Chen TQ; Li CZ; Ni SF; Shi M; Luo GX; Dong DX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1983 Dec; 5(6):373-7. PubMed ID: 6327097
    [No Abstract]   [Full Text] [Related]  

  • 18. Surveillance and control of poliomyelitis in The Netherlands.
    Bijkerk H
    Rev Infect Dis; 1984; 6 Suppl 2():S451-6. PubMed ID: 6330840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term immunity to poliovirus in children immunized with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccines.
    Faden H; Duffy L; Sun M; Shuff C
    J Infect Dis; 1993 Aug; 168(2):452-4. PubMed ID: 8335983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humoral and mucosal immunity in infants induced by three sequential inactivated poliovirus vaccine-live attenuated oral poliovirus vaccine immunization schedules. Baltimore Area Polio Vaccine Study Group.
    Modlin JF; Halsey NA; Thoms ML; Meschievitz CK; Patriarca PA
    J Infect Dis; 1997 Feb; 175 Suppl 1():S228-34. PubMed ID: 9203721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.